Vimarsana
Biggest News Aggregation in the World

Page 2 - About Edison News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from About Edison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In About Edison Today - Breaking & Trending Today

Axiom European Financial Debt Fund (AXI): Initiation - Capital opportunities - Vimarsana News

Axiom European Financial Debt Fund (AXI): Initiation - Capital opportunities

Axiom European Financial Debt Fund (AXI): Initiation - Capital opportunities DJ Axiom European Financial Debt Fund (AXI): Initiation - Capital opportunities Edison Investment Research Limited Axiom European Financial Debt Fund (AXI): Initiation - Capital opportunities 14-Apr-2021 / 08:08 GMT/BST =---------------------------------------------------------------------------------------------------------------------- London, UK, 14 April 2021 Axiom European Financial Debt Fund (AXI): Initiation - Capital opportunities Axiom European Financial Debt Fund (AXI) is a closed-end fund that invest...

Edison Investment Research Limited: Schaltbau Holding (SLT): Initiation - DC specialist on the verge of margin recovery - Vimarsana News

Edison Investment Research Limited: Schaltbau Holding (SLT): Initiation - DC specialist on the verge of margin recovery

(0) DJ Edison Investment Research Limited: Schaltbau Holding (SLT): Initiation - DC specialist on the verge of margin recovery Edison Investment Research Limited Edison Investment Research Limited: Schaltbau Holding (SLT): Initiation - DC specialist on the verge of margin recovery 09-Apr-2021 / 07:35 GMT/BST =---------------------------------------------------------------------------------------------------------------------- London, UK, 9 April 2021 Schaltbau Holding (SLT): Initiation - DC specialist on the verge of margin recovery Schaltbau Holding should benefit from trends towards d...

Ultimovacs (ULTI): Initiation - Cancer vaccine with virtually universal potential - Vimarsana News

Ultimovacs (ULTI): Initiation - Cancer vaccine with virtually universal potential

Ultimovacs (ULTI): Initiation - Cancer vaccine with virtually universal potential DJ Ultimovacs (ULTI): Initiation - Cancer vaccine with virtually universal potential Edison Investment Research Limited Ultimovacs (ULTI): Initiation - Cancer vaccine with virtually universal potential 17-March-2021 / 09:07 GMT/BST =---------------------------------------------------------------------------------------------------------------------- London, UK, 17 March 2021 Ultimovacs (ULTI): Initiation - Cancer vaccine with virtually universal potential Ultimovacs is a biotechnology company focused on d...

Edison Investment Research Limited: OPG Power Ventures (OPG.L): Initiation - Vimarsana News

Edison Investment Research Limited: OPG Power Ventures (OPG.L): Initiation

Edison Investment Research Limited: OPG Power Ventures (OPG.L): Initiation - Full power ahead DJ Edison Investment Research Limited: OPG Power Ventures (OPG.L): Initiation - Full power ahead Edison Investment Research Limited Edison Investment Research Limited: OPG Power Ventures (OPG.L): Initiation - Full power ahead 11-March-2021 / 11:41 GMT/BST =---------------------------------------------------------------------------------------------------------------------- London, UK, 11 March 2021 OPG Power Ventures (OPG.L): Initiation - Full power ahead OPG has proved financially resilient th...

AdAlta (1AD): Initiation - Targeting IPF with its i-body platform - Vimarsana News

AdAlta (1AD): Initiation - Targeting IPF with its i-body platform

AdAlta (1AD): Initiation - Targeting IPF with its i-body platform DJ AdAlta (1AD): Initiation - Targeting IPF with its i-body platform Edison Investment Research Limited AdAlta (1AD): Initiation - Targeting IPF with its i-body platform 22-Feb-2021 / 20:00 GMT/BST =---------------------------------------------------------------------------------------------------------------------- London, UK, 22 February 2021 AdAlta (1AD): Initiation - Targeting IPF with its i-body platform AdAlta is a clinical-stage company that uses its proprietary i-body discovery platform to target diseases, with a...